The reduction in tumor growth following LY411575 or clodronate was accompanied by a depletion of CD11b+F4/80+ TAMs (Fig. 1E), specifically the CD206+ M2-like, immunosuppressive and protumoral phenotype (45, 46) (fig. This evidence concerns the gene MRC1 and neoplasm.